Omeros Corporation (OMER)
NASDAQ: OMER · Real-Time Price · USD
17.71
+0.54 (3.15%)
Sep 16, 2026, 2:17 PM EDT - Market open
Omeros Employees
Omeros had 175 employees as of December 31, 2025. The number of employees decreased by 27 or -13.37% compared to the previous year.
Employees
175
Change (1Y)
-27
Growth (1Y)
-13.37%
Revenue / Employee
$219,554
Profits / Employee
$713,291
Market Cap
1.28B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 175 | -27 | -13.37% |
| Dec 31, 2024 | 202 | 4 | 2.02% |
| Dec 31, 2023 | 198 | 2 | 1.02% |
| Dec 31, 2022 | 196 | -17 | -7.98% |
| Dec 31, 2021 | 213 | -64 | -23.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Maze Therapeutics | 141 |
| Alpha Tau Medical | 121 |
| ORIC Pharmaceuticals | 111 |
| Cullinan Therapeutics | 109 |
| Tyra Biosciences | 87 |
| Vor Biopharma | 76 |
| Savara | 70 |
| Alto Neuroscience | 68 |
OMER News
- 4 weeks ago - Omeros reports Q2 adjusted EPS 2c vs (24c) last year - TheFly
- 4 weeks ago - Omeros Earnings Call Transcript: Q2 2026 - Transcripts
- 4 weeks ago - Omeros Earnings release: Q2 2026 - Filings
- 4 weeks ago - Omeros Quarterly report: Q2 2026 - Filings
- 4 weeks ago - Omeros Corporation Reports Second Quarter 2026 Financial Results - Business Wire
- 5 weeks ago - Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026 - Business Wire
- 6 weeks ago - Omeros grants new technology add-on payment status to Yartemlea - TheFly
- 6 weeks ago - CMS Grants New Technology Add-On Payment (NTAP) Status to YARTEMLEA® - Business Wire